Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Liangping Li

4PUBLICATIONS

4CO-AUTHORS

Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Electrical energy generation (incl. renewables, excl. photovoltaics)Cancer therapy (excl. chemotherapy and radiation therapy)

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (4)

Sort by Publication Date:

|Jul 07, 2022

Natural high-avidity T-cell receptor efficiently mediates regression of cancer/testis antigen 83 positive common solid cancers.

Qingyang Li, Wei Hu, Baoyi Liao

|Mar 01, 2022

Correction to: Generation of individualized immunocompatible endothelial cells from HLA-I-matched human pluripotent stem cells.

Chanchan Song, Linli Wang, Qingyang Li

|Feb 03, 2022

Generation of individualized immunocompatible endothelial cells from HLA-I-matched human pluripotent stem cells.

Chanchan Song, Linli Wang, Qingyang Li

|Apr 14, 2021

Complete rejection of large established breast cancer by local immunochemotherapy with T cell activation against neoantigens.

Junxia Gao, Xianlin Yuan, Jia Yuan

Pageof 1

Frequent Collaborators

1 joint publications

Qingyang Li

1 joint publications

Wei Hu

1 joint publications

Baoyi Liao

1 joint publications

Chanchan Song

Frequent Collaborators

1 joint publications

Qingyang Li

1 joint publications

Wei Hu

1 joint publications

Baoyi Liao

1 joint publications

Chanchan Song

Top Related Videos

Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors

Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors

Published on : Dec 16, 2022

Hemogenic Endothelium Differentiation from Human Pluripotent Stem Cells in A Feeder- and Xeno-free Defined Condition

Hemogenic Endothelium Differentiation from Human Pluripotent Stem Cells in A Feeder- and Xeno-free Defined Condition

Published on : Jun 16, 2019

See more related videos

Top Related Videos

Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors

Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors

Published on : Dec 16, 2022

Hemogenic Endothelium Differentiation from Human Pluripotent Stem Cells in A Feeder- and Xeno-free Defined Condition

Hemogenic Endothelium Differentiation from Human Pluripotent Stem Cells in A Feeder- and Xeno-free Defined Condition

Published on : Jun 16, 2019

See more related videos